---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-121064"
form_type: "8-K"
ticker: "BRKR"
cik: "0001109354"
company_name: "BRUKER CORP"
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:09:27.580326+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bruker Q3 revenue up 16.4% but GAAP EPS $0.27 down from $0.60; FY2024 guidance lowered

## Summary
- Q3 revenue $864.4M, up 16.4% YoY; organic growth 3.1%, CER growth 15.7%.
- GAAP EPS $0.27 vs $0.60 prior year; non-GAAP EPS $0.60 vs $0.74, down 18.9%.
- BSI segment organic revenue grew 3.8% YoY; BEST segment organic revenue declined 3.2%.
- FY2024 revenue guidance lowered to $3.34-$3.37B (organic growth 3-4%); non-GAAP EPS $2.36-$2.41.
- Management cites persistent biopharma and China headwinds as reason for guidance cut.

## SEC filing metadata
- accession: 0000950170-24-121064
- form_type: 8-K
- ticker: BRKR
- cik: 0001109354
- company_name: BRUKER CORP
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1109354/000095017024121064/0000950170-24-121064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1109354/000095017024121064/brkr-20241105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-121064
- JSON: https://secwatch.observer/filing/0000950170-24-121064.json
- Plain text: https://secwatch.observer/filing/0000950170-24-121064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.